AR075187A1 - Composicon que comprende acido caftarico y/o sus derivados, uso, kit - Google Patents

Composicon que comprende acido caftarico y/o sus derivados, uso, kit

Info

Publication number
AR075187A1
AR075187A1 ARP100100203A ARP100100203A AR075187A1 AR 075187 A1 AR075187 A1 AR 075187A1 AR P100100203 A ARP100100203 A AR P100100203A AR P100100203 A ARP100100203 A AR P100100203A AR 075187 A1 AR075187 A1 AR 075187A1
Authority
AR
Argentina
Prior art keywords
composition
acid
treat
composition according
derivatives
Prior art date
Application number
ARP100100203A
Other languages
English (en)
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of AR075187A1 publication Critical patent/AR075187A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14—Yeasts or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)

Abstract

Una composicion que permite suministrarle a un sujeto ácido tartárico y/o cafeico. Una composicion que comprende un ingrediente que contiene ácido caftárico y/o sus derivados, y una bacteria de ácido láctico capaz de hidrolizar ácido caftárico y /o sus derivados para generar ácido tartárico y/o cafeico. Reivindicacion 4: La composicion de acuerdo con cualquiera de las reivindicaciones 1 - 3, caracterizada porque la composicion es un producto alimenticio, un suplemento alimenticio o una bebida, o una composicion para la aplicacion parenteral. Reivindicacion 7: La composicion de acuerdo con cualquiera de las reivindicaciones 1 - 6, caracterizada porque la bacteria de ácido láctico se selecciona del grupo que consiste en L. johnsonii, B. Iongum y B. lactis, en particular Lactobacillus johnsonii (CNCM I-1225), B. longum BB 536, B. Iactis (CNCM I-3446) y B. lactis BB12. Reivindicacion 8: La composicion de acuerdo con cualquiera de las reivindicaciones 1 - 7, caracterizada porque el ingrediente que contiene ácido caftárico es un producto alimenticio natural, tal como lechuga, achicoria, diente de leon, uva, pulpa de uva; o combinaciones o extractos de éstos. Reivindicacion 9: Uso de una composicion de acuerdo con una de las reivindicaciones 1 - 8, caracterizada porque es para la preparacion de una composicion para tratar o prevenir trastornos inflamatorios, en particular ligados a infecciones bacterianas y/o virales; para mejorar la capacidad antioxidante en un humano o animal; para tratar o prevenir los trastornos relacionados con el estrés oxidativo; para tratar o prevenir trastornos metabolicos, tales como diabetes; para tratar o prevenir trastornos relacionados con la densidad mineral osea; y/o para tratar o prevenir el cáncer.
ARP100100203A 2009-01-27 2010-01-27 Composicon que comprende acido caftarico y/o sus derivados, uso, kit AR075187A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09151383A EP2210505A1 (en) 2009-01-27 2009-01-27 Composition comprising caftaric acid and/or derivatives thereof

Publications (1)

Publication Number Publication Date
AR075187A1 true AR075187A1 (es) 2011-03-16

Family

ID=40670988

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100100203A AR075187A1 (es) 2009-01-27 2010-01-27 Composicon que comprende acido caftarico y/o sus derivados, uso, kit

Country Status (14)

Country Link
US (1) US20120020926A1 (es)
EP (2) EP2210505A1 (es)
JP (1) JP2012515542A (es)
KR (1) KR20110119724A (es)
CN (1) CN102333459A (es)
AR (1) AR075187A1 (es)
AU (1) AU2010209806A1 (es)
BR (1) BRPI1007413A2 (es)
CA (1) CA2750686A1 (es)
CO (1) CO6390087A2 (es)
MX (1) MX2011007472A (es)
RU (1) RU2011135795A (es)
WO (1) WO2010086331A2 (es)
ZA (1) ZA201106299B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103025308B (zh) * 2010-06-30 2017-04-05 雀巢产品技术援助有限公司 咖啡酰酒石酸及衍生物在食品补充剂中用于调节皮肤色素沉着的用途
CA2803465C (en) * 2010-06-30 2018-12-11 Nestec S.A. Use of caftaric acid and lactic bacterium in food supplement for regulating skin pigmentation
SG10201505158UA (en) * 2010-06-30 2015-08-28 Nestec Sa Use of chicoric acid and derivatives for regulating skin pigmentation
JP2014508186A (ja) * 2011-03-17 2014-04-03 プロバイオティカル・ソシエタ・ペル・アチオニ 抗酸化活性を有するプロバイオティクス細菌およびそれらの使用
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
CN102531902A (zh) * 2011-10-20 2012-07-04 沈阳双鼎制药有限公司 一种咖啡酰酒石酸及其制备方法和用途
JP2015521613A (ja) 2012-06-22 2015-07-30 ネステク ソシエテ アノニム 神経変性に対するプロバイオティクス及びポリフェノール
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
KR20170032815A (ko) * 2015-09-15 2017-03-23 경희대학교 산학협력단 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물
KR102475667B1 (ko) * 2020-08-07 2022-12-07 김성수 유산균을 포함하는 스트레스 완화, 수면 장애 개선 및 숙면 유지용 조성물
US20240307338A1 (en) * 2021-01-27 2024-09-19 Sichuan Jiuzhang Biological Science And Technology Co., Ltd. Use of pharmaceutical composition containing chlorogenic acid in preparation of medicament for treating pathologic jaundice

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5799193A (en) * 1980-12-08 1982-06-19 Kikkoman Corp Novel enzyme hydrolyzing hydroxy cinnamic ester and its preparation
FR2591073B1 (fr) * 1985-12-10 1988-02-19 Leroux Sarl Chicoree Boisson a base de chicoree et procede de preparation de ladite boisson
CA2245810A1 (en) * 1996-02-14 1997-08-21 The Procter & Gamble Company Urogenital and intestinal compositions
US20030185811A1 (en) * 2001-02-06 2003-10-02 Steve Teasdale Herbal extract and preparation thereof
FR2827774B1 (fr) * 2001-07-30 2005-06-24 Dolisos Lab Preparations pharmaceutiques et/ou dietetiques contenant un extrait vegetal titre en composes actifs et des micro-organismes probiotiques
JP2003250528A (ja) * 2002-03-06 2003-09-09 Yakult Honsha Co Ltd ビフィドバクテリウム属細菌の生残性改善剤、増殖促進剤、又は、同細菌含有醗酵物の製造方法
US6953574B2 (en) * 2002-06-21 2005-10-11 Technology Commercialization, Inc. Method for producing a fermented hydrolyzed medium containing microorganisms
US20040001898A1 (en) * 2002-06-26 2004-01-01 Armand Malnoe Compositions and methods for detoxification and cancer prevention
ATE534303T1 (de) * 2003-03-25 2011-12-15 Univ Aarhus Verfahren zur verbesserung der fleischqualität, gesundheitsstatus bei tieren und umwelteinfluss
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
FR2886817B1 (fr) * 2005-06-10 2007-08-24 Gervais Danone Sa Produit alimentaire enrichi en probiotique et appauvri en acides organiques
US7767235B2 (en) * 2005-09-28 2010-08-03 Constellation Brands, Inc. Grape extract, dietary supplement thereof, and processes therefor
FR2904935A1 (fr) * 2006-08-18 2008-02-22 Centre Nat Rech Scient Composition antidiabetique apte a stimuler la secretion d'insuline et destinee au traitement du diabete de type 2 (diabete non insulino-dependant).
FR2906109B1 (fr) * 2006-09-22 2009-09-04 Physcience Soc Par Actions Sim Complement alimentaire pour la prevention et la lutte contre les infections urinaires
DE602007001324D1 (de) * 2006-10-13 2009-07-30 Gervais Danone Sa Neue Zusammensetzung zur Verbesserung des Hautzustandes und Verfahren zu ihrer Herstellung
JP4990297B2 (ja) * 2007-02-01 2012-08-01 株式会社Ｔｋバイオ研究所 ブドウ果皮・種子乳酸菌発酵物及びそれを利用した医薬

Also Published As

Publication number Publication date
BRPI1007413A2 (pt) 2015-08-25
ZA201106299B (en) 2014-01-29
AU2010209806A1 (en) 2011-07-28
US20120020926A1 (en) 2012-01-26
EP2210505A1 (en) 2010-07-28
WO2010086331A2 (en) 2010-08-05
CO6390087A2 (es) 2012-02-29
KR20110119724A (ko) 2011-11-02
MX2011007472A (es) 2011-08-03
EP2391230A2 (en) 2011-12-07
CN102333459A (zh) 2012-01-25
CA2750686A1 (en) 2010-08-05
WO2010086331A3 (en) 2010-09-30
JP2012515542A (ja) 2012-07-12
RU2011135795A (ru) 2013-03-10

Similar Documents

Publication Publication Date Title
AR075187A1 (es) Composicon que comprende acido caftarico y/o sus derivados, uso, kit
AR075188A1 (es) Composicion que comprende acido chicorico y/o sus derivados, uso, kit
BR132020021160E2 (pt) composição compreendendo um fermentado de bactéria probiótica lactobacillus paracasei cba l74 e uso do mesmo
MY172363A (en) Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof
EA201391500A1 (ru) Синергический противомикробный эффект
AR076862A1 (es) Microorganismos no replicantes y su efecto de refuerzo inmunologico. composicion. metodo para aumentar efectividad de probioticos
AR076677A1 (es) Bifidobacterium longum ncc2705 (cncm i-2618) y trastornos inmunes.
MX347262B (es) Preparaciones de alimento para mascotas que contienen microorganismos probióticos.
UA109112C2 (uk) Короткотривала високотемпературна обробка, що дозволяє одержати мікробні препарати із протизапальними профілями
IN2012DN01638A (es)
MX354047B (es) Cepas/celulas de lactobacillus secadas por aspersion, y el uso de las mismas contra helicobacter pylori.
MX2013004372A (es) Productos de confiteria que contienen microorganismos probioticos.
BR112015022833A2 (pt) bactéria de ácido láctico ou um fragmento da mesma, bactéria de ácido láctico isolada ou um fragmento da mesma, uso de bactérias de ácido láctico ou um fragmento das mesmas, composição alimentícia, método para conservação de gêneros alimentícios, e, método de identificação de uma bactéria de ácido láctico
WO2019004684A3 (ko) 나노화된 김치 유산균을 함유하는 피부 주름 개선 또는 피부 보습용 화장료 조성물
BR112019001984A2 (pt) bactérias lácticas e a sua utilização para tratamento prevenção, inibição e/ou redução da formação de biofilmes bacterianos
LT2009060A (en) Algae spirulina platensis preservation by natural honey
DOP2016000134A (es) Complejos de cobre-amonio y de cobre-zinc-amonio solubilizados con ácidos, composiciones, preparaciones, métodos y usos.
CL2019001194A1 (es) Extracto de una composición herbal como agente antimicrobiano y/o antibiopelícula.
IN2012DN02283A (es)
MX357554B (es) Concentrado o extracto de brote de aloe vera que tiene efectos superiores de promoción de célula de la piel, antioxidantes y anti-alergia.
MX2013003541A (es) Alimento fermentado y metodo para producir el mismo.
RU2012155857A (ru) Применение цикориевой кислоты и молочнокислых бактерий в биологически активной добавке к пище для регулирования пигментации кожи
MY197917A (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
CO6290789A2 (es) Cepas de lactobacillus como probioticos con efecto inmunomodulador especifico
RU2013120495A (ru) Мононенасыщенная жирная кислота для профилактики и/или лечения недостатков цвета и внешнего вида кожи

Legal Events

Date Code Title Description
FA Abandonment or withdrawal